Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

The NYSE debut is the first major IPO for a venture-backed digital-health company since the pandemic-era boom. The top lender, advised by law firm Paul Weiss, is in discussions to take over the ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Robin Zeng’s high-stakes bets—from quitting his first job to founding CATL—have reshaped the global EV battery market.

Hydrogen Power Technology, a rising player in the hydrogen fuel cell and drone scene, has big plans on the horizon. The China ...

Yatsen's shares now trade more than 50% below their IPO price, and its price to sales ratio (P/S) of 0.99 is well behind the ...

The fintech firm is betting on global expansion and AI-driven financial infrastructure to anchor its next phase of growth.

Mod­er­na pulls BLA for its Covid-flu shot: The com­pa­ny sug­gest­ed on its most re­cent … Get free access to a limited ...

Trade tensions with the US show little sign of denting faith in China's EV sector, after battery-maker CATL pulled off the ...